Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents

• Asıl Yazarlar: Yan Wang (Yazar), Yuanyuan Hu (Yazar), Ting Wang (Yazar), Guowei Che (Yazar), Lu Li (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2023-03-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background and purpose: Previous studies have found that metformin can inhibit tumor growth and improve outcomes for cancer patients. However, the association between the addition of metformin to the treatment regimen and survival in non-small cell lung cancer (NSCLC) patients receiving antineoplast...